MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-14-0081540
Genu Path Labs Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.28 Cr
▲ 3% YoY
Net loss · FY 2025
₹5.75 Cr
Net margin -175.3%
EBITDA · FY 2025
-₹5.32 Cr
EBITDA margin -161.9%
Authorised capital
₹19.75 Cr
Registered with MCA
Paid-up capital
₹19.75 Cr
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
42
Provident fund records
Directors on board
5
As per MCA filings
About Genu Path Labs Limited
Data last updated:
Genu Path Labs Limited is a public limited company based in Kolkata, West Bengal, India, a subsidiary of Sastasundar Healthbuddy Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 01 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85320WB2017PLC222577.
The company has an authorised share capital of ₹19.75 Cr and a paid-up capital of ₹19.75 Cr. It is led by directors including Bhaskar Bhattacharya (Whole-Time Director) and Ravi Kant Sharma.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Innovation Tower Premises No.16 – 315 Plot No.Dh6/32 Action Area – 1D Newtown, Kolkata, West Bengal, India – 700156.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.28 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹5.75 Cr (net margin -175.3%) and EBITDA of -₹5.32 Cr (EBITDA margin -161.9%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 42 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Genu Path Labs. The company has 6 deals on record (2 acquisitions, 2 rights issues, 1 funding round), with disclosed funding of ₹2 Cr; the latest was in December 2019.
Genu Path Labs Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0081540). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genupathlabs.com.
Company details
CIN U85320WB2017PLC222577
Registration Number 222577
Incorporation Date 01 September 2017
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Sastasundar Healthbuddy Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-14-0081540
Key People
Bhaskar Bhattacharya Whole-Time Director Ravi Kant Sharma Director Parimal Kumar Chattaraj Director Recognitions & Rankings of Genu Path Labs
Contact details
Genu Path Labs Limited's registered office is in Kolkata, West Bengal. Its website is genupathlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressInnovation Tower Premises No.16 – 315 Plot No.Dh6/32 Action Area – 1D Newtown, Kolkata, West Bengal, India – 700156
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Genu Path Labs Limited, buy the company report.
Comprehensive company report
Genu Path Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Genu Path Labs operates one associated brand: Genu Path Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides an online platform for booking diagnostic tests and appointments. | genupathlabs.com |
Business activity
The main business activity of Genu Path Labs is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Genu Path Labs Limited, buy the company report.
Financials of Genu Path Labs Limited
FY 2025 filings availableGenu Path Labs Limited reported revenue of ₹3.28 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹3.28 Cr ▲ 3%
Net loss · FY 2025
₹5.75 Cr margin -175.3%
EBITDA · FY 2025
-₹5.32 Cr margin -161.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 13%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▼ 1%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 3% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.75 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -161.9% | ||||
| Net Profit Margin | -175.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genu Path Labs Limited, buy the company report.
Board of directors of Genu Path Labs Limited
Genu Path Labs has 5 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskar Bhattacharya Also directs: Future Terra LLP | Whole-Time Director | 20 Dec 2019 | 6 Years 10 Months | Current |
| Ravi Kant Sharma Also directs: Health X Platform Limited, Sastasundar Healthbuddy Limited, Microsec Resources Private Limited and 1 more | Director | 01 Sep 2017 | 9 Years 2 Months | Current |
| Parimal Kumar Chattaraj | Director | 07 Aug 2020 | 6 Years 3 Months | Current |
| Paritosh Nandi | Director | 01 Apr 2021 | 5 Years 7 Months | Current |
| Banwari Lal Mittal Also directs: Health X Platform Limited, Sastasundar Healthbuddy Limited, Microsec Resources Private Limited and 5 more | Director | 01 Sep 2017 | 9 Years 2 Months | Current |
Auditor
Genu Path Labs Limited is audited by Singhi & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Singhi & Co. | FY 2024 | 302049E |
Shareholding
The shareholding of Genu Path Labs Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Genu Path Labs Limited, buy the company report.
Deals & funding
Genu Path Labs Limited has 6 deals on record (2 acquisitions, 2 rights issues, 1 funding round), with disclosed funding of ₹2 Cr; the latest was in December 2019.
Total deals
6
Acquisitions
2
Rights issues
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹2 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2019 | Rights issue | ₹5 Cr | Investors: Health X Platform Limited |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Sastasundar Healthbuddy Limited Seller: Health X Platform Limited |
| Mar 2019 | Funding round | ₹2 Cr | Investors: Health X Platform Limited |
| Aug 2018 | Rights issue | ₹2 Cr | Investors: Health X Platform Limited |
| Feb 2018 | Acquisition | ₹1.9 Cr | Buyer: Health X Platform Limited |
To see the full deal history of Genu Path Labs Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Genu Path Labs Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genu Path Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Genu Path Labs Limited has a workforce of 42 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
42
Active EPFO establishments
1
Employee growth
-42.5%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 42 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Genu Path Labs Limited, buy the company report.
GST
No GST registration is on our record for Genu Path Labs Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genu Path Labs Limited has 12 board changes on record since 2017: 5 appointments and 7 cessations. The latest: Sachin Kumar Mittal ceased to be Additional Director on 16 Sep 2024.
AGM
Genu Path Labs Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Filing
Genu Path Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Sachin Kumar Mittal ceased to be Additional Director.
Ceased
Paritosh Nandi ceased to be Additional Director.
Appointed
Paritosh Nandi was appointed as Director.
Ceased
Saibal Chandra Pal ceased to be Director.
Ceased
Biplab Kumar Mani ceased to be Company Secretary.
Ceased
Bhaskar Bhattacharya ceased to be Additional Director.
Ceased
Parimal Kumar Chattaraj ceased to be Additional Director.
Appointed
Parimal Kumar Chattaraj was appointed as Director.
Appointed
Bhaskar Bhattacharya was appointed as Whole-Time Director.
Ceased
Amrit Daga ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Genu Path Labs is an active public limited company based in Kolkata, West Bengal, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 01 September 2017 (9+ years old) and is registered under CIN U85320WB2017PLC222577.
Genu Path Labs has 5 current directors:
- Bhaskar Bhattacharya - Whole-Time Director
- Ravi Kant Sharma - Director
- Parimal Kumar Chattaraj - Director
- Paritosh Nandi - Director
- Banwari Lal Mittal - Director
The latest financial statements of Genu Path Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Genu Path Labs is U85320WB2017PLC222577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genu Path Labs was incorporated on 01 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
Genu Path Labs has 6 deals on record (2 acquisitions, 2 rights issues, 1 funding round), with disclosed funding of ₹2 Cr; the latest was in December 2019.
Sachin Kumar Mittal ceased to be Additional Director on 16 Sep 2024. Paritosh Nandi ceased to be Additional Director on 23 Sep 2021. Paritosh Nandi was appointed as Director on 01 Apr 2021. Genu Path Labs has 12 board changes on record in total.
Yes, Genu Path Labs is registered as a small enterprise under Udyam registration (number: UDYAM-WB-14-0081540).
Genu Path Labs can be reached through the website genupathlabs.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Genu Path Labs is at Innovation Tower Premises No.16 – 315 Plot No.Dh632 Action Area – 1D Newtown, Kolkata, West Bengal, India – 700156.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages